Credit Suisse’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-44,484
| Closed | -$149K | – | 3807 |
|
|
2017
Q2 | $149K | Sell |
44,484
-38,846
| -47% | -$130K | ﹤0.01% | 3287 |
|
|
2017
Q1 | $767K | Sell |
83,330
-8,616
| -9% | -$79.3K | ﹤0.01% | 2700 |
|
|
2016
Q4 | $709K | Buy |
91,946
+125
| +0.1% | +$964 | ﹤0.01% | 2918 |
|
|
2016
Q3 | $1.05M | Sell |
91,821
-15,708
| -15% | -$180K | ﹤0.01% | 2600 |
|
|
2016
Q2 | $1.32M | Buy |
107,529
+24,666
| +30% | +$303K | ﹤0.01% | 2415 |
|
|
2016
Q1 | $838K | Buy |
82,863
+3,140
| +4% | +$31.8K | ﹤0.01% | 2578 |
|
|
2015
Q4 | $1.8M | Sell |
79,723
-2,700
| -3% | -$60.9K | ﹤0.01% | 2173 |
|
|
2015
Q3 | $1.37M | Sell |
82,423
-27,985
| -25% | -$464K | ﹤0.01% | 2374 |
|
|
2015
Q2 | $2.48M | Buy |
110,408
+28,617
| +35% | +$644K | ﹤0.01% | 2149 |
|
|
2015
Q1 | $2.11M | Buy |
81,791
+61,045
| +294% | +$1.57M | ﹤0.01% | 2125 |
|
|
2014
Q4 | $451K | Buy |
20,746
+7,822
| +61% | +$170K | ﹤0.01% | 3428 |
|
|
2014
Q3 | $244K | Sell |
12,924
-13,362
| -51% | -$252K | ﹤0.01% | 3646 |
|
|
2014
Q2 | $612K | Buy |
26,286
+13,757
| +110% | +$320K | ﹤0.01% | 3273 |
|
|
2014
Q1 | $422K | Buy |
+12,529
| New | +$422K | ﹤0.01% | 3476 |
|